We are currently seeking an Associate Director, Clinical Research Scientist (CRS) to join our Clinical Development Group. This position will report to the Senior Medical Director and play a role in the design, execution, and oversight of clinical trials in the CNS space.
Lead clinical data review activities for assigned studies or programs, ensuring data quality and timely identification of key findings.
Support DSMB activities, including preparation of materials and interpretation of outputs.
Contribute to the development of clinical study protocols, ensuring alignment with program objectives and regulatory requirements.
Partner with cross-functional teams to define study endpoints, inclusion/exclusion criteria, and research methodologies.
Oversee the selection and validation of clinical outcome measures and data collection methods.
Conduct comprehensive literature reviews to support clinical trial design and development plans.
Summarize and present clinical data and insights to cross-functional teams; contribute to leadership presentations as needed.
Contribute to the creation and execution of clinical development plans spanning early to late-phase development (Phase 1-3).
Research opportunities for new indications for a given molecule.
Provide scientific input into regulatory documents and support health authority interactions, including FDA communications.
Monitor the competitive landscape and emerging science in CNS/neurology, sharing relevant insights with the team.
Contribute to scientific publications, including abstracts, manuscripts, and presentations at medical conferences.
Establish and maintain relationships with key opinion leaders (KOLs), clinical investigators, and external experts.
Advanced degree (Ph.D. or Pharm.D.) in a neuroscience or a related field.
Minimum of 6-8 years of experience in clinical research within the pharmaceutical or biotechnology industry, with demonstrated experience in clinical trial design and execution.
Strong expertise in neurology and CNS disorders.
Proven track record of leading clinical research initiatives and contributing to strategic development plans.
Experience interacting with clinical investigators, and key medical experts.
Strong knowledge of ICH, GCP and other relevant regulatory guidelines.
Exceptional communication and collaboration skills to work effectively in a matrixed environment.
The annual base salary for this position ranges from $188,000 to $212,000. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here
Why join Team Alkermes?
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.
Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment.
Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
